Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
ACS Medicinal Chemistry Letters|November 17, 2022
Structure-Activity Relationships for the N-Me- Versus N-H-Amide Modification to Macrocyclic ent-Verticilide AntiarrhythmicsAbigail N Smith, Madelaine P Thorpe, Daniel J Blackwell, et al.
Circulation Research|December 10, 2020
RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVTDmytro O Kryshtal, Daniel J Blackwell, Christian L Egly, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2025
Structural Evaluation of RYR2-CPVT Missense Variants and Continuous Bayesian Estimates of their PenetranceKohei Yamauchi, Matthew Ku, Devyn W Mitchell, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 9, 2023
In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule ent-VerticilideDaniel J Blackwell, Abigail N Smith, Tri Do, et al.
Journal of Molecular and Cellular Cardiology Plus|May 9, 2023
Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathyVasco Sequeira, Lili Wang, Paul J M Wijnker, et al.
Journal of Molecular and Cellular Cardiology Plus|December 18, 2024
Conditional ablation of MCU exacerbated cardiac pathology in a genetic arrhythmic model of CPVTArpita Deb, Brian D Tow, Jie Hao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2019
Unnatural verticilide enantiomer inhibits type 2 ryanodine receptor-mediated calcium leak and is antiarrhythmicSuzanne M Batiste, Daniel J Blackwell, Kyungsoo Kim, et al.
Structure (London, England : 1993)|April 3, 2018
A Mechanism of Calmodulin Modulation of the Human Cardiac Sodium ChannelChristopher N Johnson, Franck Potet, Matthew K Thompson, et al.
Pageof 8